BioCryst Pharmaceuticals, Inc. (BCRX) Posts Q1 Loss of 9c/Share

May 7, 2013 6:08 AM

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) reported Q1 EPS of ($0.09), $0.06 better than the analyst estimate of ($0.15). Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found